These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8761585)

  • 21. Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire.
    Jamonneau V; Solano P; Garcia A; Lejon V; Djé N; Miezan TW; N'Guessan P; Cuny G; Büscher P
    Trop Med Int Health; 2003 Jul; 8(7):589-94. PubMed ID: 12828540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy and chemoprophylaxis of sleeping sickness caused by Trypanosoma gambiense].
    NEUJEAN G
    Rev Med Liege; 1959 Jan; 14(1):5-13. PubMed ID: 13634721
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire.
    Bronner U; Doua F; Ericsson O; Gustafsson LL; Miézan TW; Rais M; Rombo L
    Trans R Soc Trop Med Hyg; 1991; 85(5):608-11. PubMed ID: 1780988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.
    Sanderson L; da Silva M; Sekhar GN; Brown RC; Burrell-Saward H; Fidanboylu M; Liu B; Dailey LA; Dreiss CA; Lorenz C; Christie M; Persaud SJ; Yardley V; Croft SL; Valero M; Thomas SA
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009276. PubMed ID: 33857146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study.
    Foulkes JR
    Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195
    [No Abstract]   [Full Text] [Related]  

  • 29. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.
    Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP
    Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.
    Pépin J; Mpia B
    Emerg Infect Dis; 2005 Jun; 11(6):921-7. PubMed ID: 15963288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment perspectives for human African trypanosomiasis.
    Bouteille B; Oukem O; Bisser S; Dumas M
    Fundam Clin Pharmacol; 2003 Apr; 17(2):171-81. PubMed ID: 12667227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human African Trypanosomiasis in a Spanish traveler returning from Tanzania.
    Gómez-Junyent J; Pinazo MJ; Castro P; Fernández S; Mas J; Chaguaceda C; Pellicé M; Gascón J; Muñoz J
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005324. PubMed ID: 28358876
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 100 Years of Suramin.
    Wiedemar N; Hauser DA; Mäser P
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
    Kennedy PGE; Rodgers J
    Front Immunol; 2019; 10():39. PubMed ID: 30740102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human African trypanosomiasis.
    Brun R; Blum J; Chappuis F; Burri C
    Lancet; 2010 Jan; 375(9709):148-59. PubMed ID: 19833383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
    [No Abstract]   [Full Text] [Related]  

  • 38. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
    Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
    Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.
    Milord F; Loko L; Ethier L; Mpia B; Pépin J
    Trans R Soc Trop Med Hyg; 1993; 87(4):473-7. PubMed ID: 8249087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.